organogenesis involves a programmed pattern of gene expression which controls cellular differentiation and morphogenesis. The developing kidney is one of the best characterized models for the study of the molecular control of organogenesis. The WT-1 gene, originally identified as a tumor suppressor gene associated with Wilms' tumors. A tumor of the kidney which occurs during childhood, is required during the inductive events at the beginning of kidney formation, and is also required for gonad formation. WT-1 is a zinc finger transcription factor with a proline-glutamine rich trans- regulatory region. The defined phenotype of the original WT-1 mutation, combined with a detailed knowledge of WT-1 action in vitro, provides an opportunity to genetically dissect at an organismic level how transcription factors regulate developmental processes in mammals. This grant proposes to undertake a more detailed mutagenic analysis to further our understanding of WT-1 function during development. Novel gene targeting approaches will be used to express mutated forms of WT-1 from the WT-1 genomic locus. Abnormal developmental phenotypes obtained will be interpreted based on morphological changes, alterations in expression of other known markers of urogenital development, and on previous studies of WT-1 function in vitro, where similar WT-1 mutations have altered its action as a transcriptional regulator. Recently, an interaction has been defined between WT-1 and the p53 tumor suppressor gene, yet p53 mutant mice have no obvious defects in urogenital development. The developmental role of p53 remains unclear; most p53 -/- embryos are normal, but a subset have neural tube defects, partially dependent on genetic background. Crossing the WT-1 and p53 mutations provides a means for determining the in vivo significance of the p53-WT-1 interaction, and provides a route for determining a developmental function of p53. Embryos carrying mutations in the WE-1 gene that lead to abnormal urogenital phenotypes will be analyzed by in situ hybridization, immunohistology, and organ culture. RNA subtraction libraries will be constructed to find novel genes expressed in urogenital development.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK050118-02
Application #
2701185
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Project Start
1997-06-10
Project End
2002-04-30
Budget Start
1998-05-01
Budget End
1999-04-30
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Qin, Shan; Taglienti, Mary; Cai, Lei et al. (2012) c-Met and NF-ýýB-dependent overexpression of Wnt7a and -7b and Pax2 promotes cystogenesis in polycystic kidney disease. J Am Soc Nephrol 23:1309-18
Qin, Shan; Taglienti, Mary; Nauli, Surya M et al. (2010) Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease. J Clin Invest 120:3617-28
Liu, Yingjie; Chattopadhyay, Nibedita; Qin, Shan et al. (2009) Coordinate integrin and c-Met signaling regulate Wnt gene expression during epithelial morphogenesis. Development 136:843-53
Natoli, Thomas A; Alberta, Julia A; Bortvin, Alex et al. (2004) Wt1 functions in the development of germ cells in addition to somatic cell lineages of the testis. Dev Biol 268:429-40
Zhang, Hong; Palmer, Rachel; Gao, Xiaobo et al. (2003) Transcriptional activation of placental growth factor by the forkhead/winged helix transcription factor FoxD1. Curr Biol 13:1625-9
Natoli, Thomas A; McDonald, Alice; Alberta, Julia A et al. (2002) A mammal-specific exon of WT1 is not required for development or fertility. Mol Cell Biol 22:4433-8
Natoli, Thomas A; Liu, Jing; Eremina, Vera et al. (2002) A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development. J Am Soc Nephrol 13:2058-67